Cargando…

Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA

Current evidence suggests that plasma cell-free DNA (cfDNA) is fragmented around a mode of 166 bp. Data supporting this view has been mainly acquired through the analysis of double-stranded cfDNA. The characteristics and diagnostic potential of single-stranded and damaged double-stranded cfDNA in he...

Descripción completa

Detalles Bibliográficos
Autores principales: Hudecova, Irena, Smith, Christopher G., Hänsel-Hertsch, Robert, Chilamakuri, Chandra S., Morris, James A., Vijayaraghavan, Aadhitthya, Heider, Katrin, Chandrananda, Dineika, Cooper, Wendy N., Gale, Davina, Garcia-Corbacho, Javier, Pacey, Simon, Baird, Richard D., Rosenfeld, Nitzan, Mouliere, Florent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805718/
https://www.ncbi.nlm.nih.gov/pubmed/34930798
http://dx.doi.org/10.1101/gr.275691.121
_version_ 1784643286507454464
author Hudecova, Irena
Smith, Christopher G.
Hänsel-Hertsch, Robert
Chilamakuri, Chandra S.
Morris, James A.
Vijayaraghavan, Aadhitthya
Heider, Katrin
Chandrananda, Dineika
Cooper, Wendy N.
Gale, Davina
Garcia-Corbacho, Javier
Pacey, Simon
Baird, Richard D.
Rosenfeld, Nitzan
Mouliere, Florent
author_facet Hudecova, Irena
Smith, Christopher G.
Hänsel-Hertsch, Robert
Chilamakuri, Chandra S.
Morris, James A.
Vijayaraghavan, Aadhitthya
Heider, Katrin
Chandrananda, Dineika
Cooper, Wendy N.
Gale, Davina
Garcia-Corbacho, Javier
Pacey, Simon
Baird, Richard D.
Rosenfeld, Nitzan
Mouliere, Florent
author_sort Hudecova, Irena
collection PubMed
description Current evidence suggests that plasma cell-free DNA (cfDNA) is fragmented around a mode of 166 bp. Data supporting this view has been mainly acquired through the analysis of double-stranded cfDNA. The characteristics and diagnostic potential of single-stranded and damaged double-stranded cfDNA in healthy individuals and cancer patients remain unclear. Here, through a combination of high-affinity magnetic bead–based DNA extraction and single-stranded DNA sequencing library preparation (MB-ssDNA), we report the discovery of a large proportion of cfDNA fragments centered at ∼50 bp. We show that these “ultrashort” cfDNA fragments have a greater relative abundance in plasma of healthy individuals (median = 19.1% of all sequenced cfDNA fragments, n = 28) than in plasma of patients with cancer (median = 14.2%, n = 21, P < 0.0001). The ultrashort cfDNA fragments map to accessible chromatin regions of blood cells, particularly in promoter regions with the potential to adopt G-quadruplex (G4) DNA secondary structures. G4-positive promoter chromatin accessibility is significantly enriched in ultrashort plasma cfDNA fragments from healthy individuals relative to patients with cancers (P < 0.0001), in whom G4-cfDNA enrichment is inversely associated with copy number aberration-inferred tumor fractions. Our findings redraw the landscape of cfDNA fragmentation by identifying and characterizing a novel population of ultrashort plasma cfDNA fragments. Sequencing of MB-ssDNA libraries could facilitate the characterization of gene regulatory regions and DNA secondary structures via liquid biopsy. Our data underline the diagnostic potential of ultrashort cfDNA through classification for cancer patients.
format Online
Article
Text
id pubmed-8805718
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cold Spring Harbor Laboratory Press
record_format MEDLINE/PubMed
spelling pubmed-88057182022-02-07 Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA Hudecova, Irena Smith, Christopher G. Hänsel-Hertsch, Robert Chilamakuri, Chandra S. Morris, James A. Vijayaraghavan, Aadhitthya Heider, Katrin Chandrananda, Dineika Cooper, Wendy N. Gale, Davina Garcia-Corbacho, Javier Pacey, Simon Baird, Richard D. Rosenfeld, Nitzan Mouliere, Florent Genome Res Research Current evidence suggests that plasma cell-free DNA (cfDNA) is fragmented around a mode of 166 bp. Data supporting this view has been mainly acquired through the analysis of double-stranded cfDNA. The characteristics and diagnostic potential of single-stranded and damaged double-stranded cfDNA in healthy individuals and cancer patients remain unclear. Here, through a combination of high-affinity magnetic bead–based DNA extraction and single-stranded DNA sequencing library preparation (MB-ssDNA), we report the discovery of a large proportion of cfDNA fragments centered at ∼50 bp. We show that these “ultrashort” cfDNA fragments have a greater relative abundance in plasma of healthy individuals (median = 19.1% of all sequenced cfDNA fragments, n = 28) than in plasma of patients with cancer (median = 14.2%, n = 21, P < 0.0001). The ultrashort cfDNA fragments map to accessible chromatin regions of blood cells, particularly in promoter regions with the potential to adopt G-quadruplex (G4) DNA secondary structures. G4-positive promoter chromatin accessibility is significantly enriched in ultrashort plasma cfDNA fragments from healthy individuals relative to patients with cancers (P < 0.0001), in whom G4-cfDNA enrichment is inversely associated with copy number aberration-inferred tumor fractions. Our findings redraw the landscape of cfDNA fragmentation by identifying and characterizing a novel population of ultrashort plasma cfDNA fragments. Sequencing of MB-ssDNA libraries could facilitate the characterization of gene regulatory regions and DNA secondary structures via liquid biopsy. Our data underline the diagnostic potential of ultrashort cfDNA through classification for cancer patients. Cold Spring Harbor Laboratory Press 2022-02 /pmc/articles/PMC8805718/ /pubmed/34930798 http://dx.doi.org/10.1101/gr.275691.121 Text en © 2022 Hudecova et al.; Published by Cold Spring Harbor Laboratory Press https://creativecommons.org/licenses/by-nc/4.0/This article, published in Genome Research, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Research
Hudecova, Irena
Smith, Christopher G.
Hänsel-Hertsch, Robert
Chilamakuri, Chandra S.
Morris, James A.
Vijayaraghavan, Aadhitthya
Heider, Katrin
Chandrananda, Dineika
Cooper, Wendy N.
Gale, Davina
Garcia-Corbacho, Javier
Pacey, Simon
Baird, Richard D.
Rosenfeld, Nitzan
Mouliere, Florent
Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA
title Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA
title_full Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA
title_fullStr Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA
title_full_unstemmed Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA
title_short Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA
title_sort characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free dna
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805718/
https://www.ncbi.nlm.nih.gov/pubmed/34930798
http://dx.doi.org/10.1101/gr.275691.121
work_keys_str_mv AT hudecovairena characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT smithchristopherg characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT hanselhertschrobert characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT chilamakurichandras characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT morrisjamesa characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT vijayaraghavanaadhitthya characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT heiderkatrin characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT chandranandadineika characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT cooperwendyn characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT galedavina characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT garciacorbachojavier characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT paceysimon characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT bairdrichardd characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT rosenfeldnitzan characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna
AT mouliereflorent characteristicsoriginandpotentialforcancerdiagnosticsofultrashortplasmacellfreedna